This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
Utilization of telehealth as part of the cancer care delivery continuum dramatically escalated in response to the COVID-19 pandemic at major cancer centers across the globe. The rapid shift toward telehealth visits for nontreatment cancer care provided immediate benefit through reducing unnecessary risk of exposure, overcoming transportation barriers faced by both patients and caregivers, and fast-tracking care transformation. As such, delineating the impact of telehealth on access, health equity, quality, and outcomes will be essential for refining the use of digital strategies and telehealth toward optimizing cancer care. Herein, experiences to date with telehealth usage for oncology care are reviewed, and priorities are outlined for postpandemic opportunities to improve the lives of patients with cancer through telemedicine.
Footnotes
Clin Cancer Res 2021;27:933–6
- Received October 5, 2020.
- Revision received November 13, 2020.
- Accepted November 18, 2020.
- Published first November 23, 2020.
- ©2020 American Association for Cancer Research.
Log in using your username and password
Purchase access
Volume 27, Issue 4
